Cargando…
1427. Treatment of Children with Acute Hematogenous Osteomyelitis and Staphylococcus aureus Bacteremia: Impact of Severity of Illness on Antimicrobial Therapy
BACKGROUND: There is limited evidence-based guidance for the treatment of children with acute hematogenous osteomyelitis (AHO) and concurrent Staphylococcus aureus bacteremia (SAB). Current guidelines emphasize the need for parenteral antibiotics in the setting of SAB, but optimal duration of parent...
Autores principales: | Copley, Lawson Ashley, Sanchez, Maria J, Sue, Paul K, Patel, Karisma, Lindsay, Eduardo A, Tareen, Naureen G, Jo, Chanhee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808674/ http://dx.doi.org/10.1093/ofid/ofz360.1291 |
Ejemplares similares
-
1430. The Hidden Costs of Vancomycin Use During the Treatment of Staphylococcus aureus Bacteremia Concurrent with Acute Hematogenous Osteomyelitis
por: Ashley. Copley, Lawson, et al.
Publicado: (2019) -
Gene Expression Analysis of Children with Acute Hematogenous Osteomyelitis Caused by Methicillin-Resistant Staphylococcus aureus: Correlation with Clinical Severity of Illness
por: Gaviria-Agudelo, Claudia, et al.
Publicado: (2014) -
Genomic Heterogeneity of Methicillin Resistant Staphylococcus aureus Associated with Variation in Severity of Illness among Children with Acute Hematogenous Osteomyelitis
por: Gaviria-Agudelo, Claudia, et al.
Publicado: (2015) -
The impact of Staphylococcus aureus genomic variation on clinical phenotype of children with acute hematogenous osteomyelitis
por: Collins, Angela, et al.
Publicado: (2018) -
Staphylococcus aureus isolates from children with clinically differentiated osteomyelitis exhibit distinct transcriptomic signatures
por: Hachem, Ahmad A., et al.
Publicado: (2023)